CBX3 deletion makes CRC cells regain IFNγ sensitivity and dramatically increased PD-L1 expression in two MSS (Microsatellite Stable) and MMR (Mismatch repair) proficient CRC cell lines (SW480 and HT29). Here, CBX3 is linked to colorectal carcinoma.